Our website is made possible by displaying non-intrusive online advertisements to our visitors.
Please consider supporting us by disabling or pausing your ad blocker.
Expecting tomypak to show meaningful growth in bottomline in the coming 3rd quarter 2018 or even as late as FY2019. This stock is for long term where investors need to patiently bear with the stage where one-off startup costs and low utilisation rate due to low commercial operation of the new production lines will continue be pull factors for the financial performance in 2018